Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention.
Rupa R PatelLeandro MenaAmy NunnTimothy McBrideLaura C HarrisonCatherine E OldenburgJingxia LiuKenneth H MayerPhilip A ChanPublished in: PloS one (2017)
Pre-exposure prophylaxis (PrEP) can reduce U.S. HIV incidence. We assessed insurance coverage and its association with PrEP utilization. We reviewed patient data at three PrEP clinics (Jackson, Mississippi; St. Louis, Missouri; Providence, Rhode Island) from 2014-2015. The outcome, PrEP utilization, was defined as patient PrEP use at three months. Multivariable logistic regression was performed to determine the association between insurance coverage and PrEP utilization. Of 201 patients (Jackson: 34%; St. Louis: 28%; Providence: 28%), 91% were male, 51% were White, median age was 29 years, and 21% were uninsured; 82% of patients reported taking PrEP at three months. Insurance coverage was significantly associated with PrEP utilization. After adjusting for Medicaid-expansion and individual socio-demographics, insured patients were four times as likely to use PrEP services compared to the uninsured (OR: 4.49, 95% CI: 1.68-12.01; p = 0.003). Disparities in insurance coverage are important considerations in implementation programs and may impede PrEP utilization.
Keyphrases
- affordable care act
- men who have sex with men
- health insurance
- hiv testing
- hiv positive
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- primary care
- prognostic factors
- hiv infected
- risk factors
- patient reported outcomes
- public health
- peritoneal dialysis
- mental health
- antiretroviral therapy
- human immunodeficiency virus
- hiv aids
- electronic health record
- data analysis